Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Cagol

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Il Giornale Di Chirurgia|March 1, 1997
[Performance and complications of totally implantable port device in bolus hepatic intra-arterial chemotherapy]D Civalleri, M Cosimelli, G Simoni, et al.
Minerva Chirurgica|November 15, 1980
[Vascular access for hemodialysis]G F Zanon, L Rui, F Sogaro, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|March 11, 1998
Differential device performances for hepatic arterial chemotherapy: a technical report on totally implantable pumps and ports for both continuous and bolus infusionD Civalleri, F De Cian, R Pellicci, et al.
Chirurgia Italiana|June 1, 1985
[Hemobilia caused by an intrahepatic aneurysm]P P Da Pian, D Miotto, G P Feltrin, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
British Journal of Cancer|July 15, 2010
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesM Cosimelli, R Golfieri, P P Cagol, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Il Giornale Di Chirurgia|March 1, 1997
[Performance and complications of totally implantable port device in bolus hepatic intra-arterial chemotherapy]D Civalleri, M Cosimelli, G Simoni, et al.
Minerva Chirurgica|November 15, 1980
[Vascular access for hemodialysis]G F Zanon, L Rui, F Sogaro, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|March 11, 1998
Differential device performances for hepatic arterial chemotherapy: a technical report on totally implantable pumps and ports for both continuous and bolus infusionD Civalleri, F De Cian, R Pellicci, et al.
Chirurgia Italiana|June 1, 1985
[Hemobilia caused by an intrahepatic aneurysm]P P Da Pian, D Miotto, G P Feltrin, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
British Journal of Cancer|July 15, 2010
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesM Cosimelli, R Golfieri, P P Cagol, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
Pageof 2